454 related articles for article (PubMed ID: 29212834)
1. Lung ageing and COPD: is there a role for ageing in abnormal tissue repair?
Brandsma CA; de Vries M; Costa R; Woldhuis RR; Königshoff M; Timens W
Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29212834
[TBL] [Abstract][Full Text] [Related]
2. Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease.
Ito K; Colley T; Mercado N
Int J Chron Obstruct Pulmon Dis; 2012; 7():641-52. PubMed ID: 23055713
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary Diseases and Ageing.
Barnes PJ
Subcell Biochem; 2019; 91():45-74. PubMed ID: 30888649
[TBL] [Abstract][Full Text] [Related]
4. Link between increased cellular senescence and extracellular matrix changes in COPD.
Woldhuis RR; de Vries M; Timens W; van den Berge M; Demaria M; Oliver BGG; Heijink IH; Brandsma CA
Am J Physiol Lung Cell Mol Physiol; 2020 Jul; 319(1):L48-L60. PubMed ID: 32460521
[TBL] [Abstract][Full Text] [Related]
5. Expression Profiling Suggests Loss of Surface Integrity and Failure of Regenerative Repair as Major Driving Forces for Chronic Obstructive Pulmonary Disease Progression.
Samaha E; Vierlinger K; Weinhappel W; Godnic-Cvar J; Nöhammer C; Koczan D; Thiesen HJ; Yanai H; Fraifeld VE; Ziesche R
Am J Respir Cell Mol Biol; 2021 Apr; 64(4):441-452. PubMed ID: 33524306
[TBL] [Abstract][Full Text] [Related]
6. Accelerated ageing of the lung in COPD: new concepts.
Mercado N; Ito K; Barnes PJ
Thorax; 2015 May; 70(5):482-9. PubMed ID: 25739910
[TBL] [Abstract][Full Text] [Related]
7. Disease of the airways in chronic obstructive pulmonary disease.
Cosio Piqueras MG; Cosio MG
Eur Respir J Suppl; 2001 Dec; 34():41s-49s. PubMed ID: 12392034
[TBL] [Abstract][Full Text] [Related]
8. Novel aspects of pathogenesis and regeneration mechanisms in COPD.
Bagdonas E; Raudoniute J; Bruzauskaite I; Aldonyte R
Int J Chron Obstruct Pulmon Dis; 2015; 10():995-1013. PubMed ID: 26082624
[TBL] [Abstract][Full Text] [Related]
9. Targeting Aging Pathways in Chronic Obstructive Pulmonary Disease.
Easter M; Bollenbecker S; Barnes JW; Krick S
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32967225
[TBL] [Abstract][Full Text] [Related]
10. Targeting accelerated pulmonary ageing to treat chronic obstructive pulmonary disease-induced neuropathological comorbidities.
De Luca SN; Vlahos R
Br J Pharmacol; 2024 Jan; 181(1):3-20. PubMed ID: 37828646
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of fluticasone on extracellular matrix production by airway and parenchymal fibroblasts in severe COPD.
Brandsma CA; Timens W; Jonker MR; Rutgers B; Noordhoek JA; Postma DS
Am J Physiol Lung Cell Mol Physiol; 2013 Oct; 305(8):L582-9. PubMed ID: 23997174
[TBL] [Abstract][Full Text] [Related]
12. Airway bacteria drive a progressive COPD-like phenotype in mice with polymeric immunoglobulin receptor deficiency.
Richmond BW; Brucker RM; Han W; Du RH; Zhang Y; Cheng DS; Gleaves L; Abdolrasulnia R; Polosukhina D; Clark PE; Bordenstein SR; Blackwell TS; Polosukhin VV
Nat Commun; 2016 Apr; 7():11240. PubMed ID: 27046438
[TBL] [Abstract][Full Text] [Related]
13. The pathology of small airways disease in COPD: historical aspects and future directions.
Higham A; Quinn AM; Cançado JED; Singh D
Respir Res; 2019 Mar; 20(1):49. PubMed ID: 30832670
[TBL] [Abstract][Full Text] [Related]
14. p16-3MR: A Novel Model to Study Cellular Senescence in Cigarette Smoke-Induced Lung Injuries.
Kaur G; Sundar IK; Rahman I
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063608
[TBL] [Abstract][Full Text] [Related]
15. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.
Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine.
Brandsma CA; Van den Berge M; Hackett TL; Brusselle G; Timens W
J Pathol; 2020 Apr; 250(5):624-635. PubMed ID: 31691283
[TBL] [Abstract][Full Text] [Related]
17. A large lung gene expression study identifying fibulin-5 as a novel player in tissue repair in COPD.
Brandsma CA; van den Berge M; Postma DS; Jonker MR; Brouwer S; Paré PD; Sin DD; Bossé Y; Laviolette M; Karjalainen J; Fehrmann RS; Nickle DC; Hao K; Spanjer AI; Timens W; Franke L
Thorax; 2015 Jan; 70(1):21-32. PubMed ID: 24990664
[TBL] [Abstract][Full Text] [Related]
18. Increased LGR6 Expression Sustains Long-Term Wnt Activation and Acquisition of Senescence in Epithelial Progenitors in Chronic Lung Diseases.
Cortesi EE; Meeusen B; Vanstapel A; Verleden SE; Vanaudenaerde BM; Wuyts WA; Janssens W; Janssens V; Roskams T; Ventura JJ
Cells; 2021 Dec; 10(12):. PubMed ID: 34943945
[TBL] [Abstract][Full Text] [Related]
19. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
[TBL] [Abstract][Full Text] [Related]
20. Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema.
Chilosi M; Carloni A; Rossi A; Poletti V
Transl Res; 2013 Sep; 162(3):156-73. PubMed ID: 23831269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
